Claus Rödel

24.3k total citations · 7 hit papers
261 papers, 16.1k citations indexed

About

Claus Rödel is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Claus Rödel has authored 261 papers receiving a total of 16.1k indexed citations (citations by other indexed papers that have themselves been cited), including 150 papers in Surgery, 131 papers in Oncology and 84 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Claus Rödel's work include Colorectal and Anal Carcinomas (86 papers), Colorectal Cancer Surgical Treatments (76 papers) and Bladder and Urothelial Cancer Treatments (35 papers). Claus Rödel is often cited by papers focused on Colorectal and Anal Carcinomas (86 papers), Colorectal Cancer Surgical Treatments (76 papers) and Bladder and Urothelial Cancer Treatments (35 papers). Claus Rödel collaborates with scholars based in Germany, United States and United Kingdom. Claus Rödel's co-authors include Rolf Sauer, Torsten Liersch, Christian Wittekind, Rainer Fietkau, Peter Martus, R. Raab, Werner Hohenberger, Heinz Becker, Clemens F. Hess and Jörg Tschmelitsch and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Claus Rödel

252 papers receiving 15.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer

2004 4.4k citations Rolf Sauer, Heinz Becker et al. New England Journal of Medicine profile →
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

2010 1.4k citations Vincenzo Valentini, Claus Rödel et al. profile →
Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer

2005 968 citations Claus Rödel, Peter Martus et al. profile →
Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.

1998 499 citations Claus Rödel et al. profile →
Combined-Modality Treatment and Selective Organ Preservation in Invasive Bladder Cancer: Long-Term Results

2002 462 citations Claus Rödel, Jürgen Dunst et al. profile →
Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials

2011 386 citations Vincenzo Valentini, Maria Antonietta Gambacorta et al. profile →
Tumor Regression Grading After Preoperative Chemoradiotherapy for Locally Advanced Rectal Carcinoma Revisited: Updated Results of the CAO/ARO/AIO-94 Trial

2014 324 citations Emmanouil Fokas, Torsten Liersch et al. profile →

Peers

Countries citing papers authored by Claus Rödel

Since Specialization

Citations

This map shows the geographic impact of Claus Rödel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claus Rödel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claus Rödel more than expected).

Fields of papers citing papers by Claus Rödel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claus Rödel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claus Rödel. The network helps show where Claus Rödel may publish in the future.

Co-authorship network of co-authors of Claus Rödel

This figure shows the co-authorship network connecting the top 25 collaborators of Claus Rödel. A scholar is included among the top collaborators of Claus Rödel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claus Rödel. Claus Rödel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	1328MO Hypofractionated radiotherapy of single tumor lesion increases systemic response rate to pembrolizumab in recurrent or metastatic head-and-neck cancer (R/M-HNSCC): Primary endpoint of the randomized Keynote-717 trial 2025 ·Annals of Oncology ·(unknown), Bálint Tamaskovics, (unknown), W. Budach, Thomas Illmer, J. Radke, Oliver Koelbl, (unknown), Patrick Melchior, (unknown), Claus Rödel, (unknown), (unknown), Anke Reinacher‐Schick, Axel Hinke, Axel Kallies, (unknown), Benjamin Frey, (unknown), (unknown)	0
2	Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma 2024 ·npj Precision Oncology ·Daniel Martin, Franz Rödel, Stephanie Hehlgans, Mario Looso, Paul K. Ziegler, Maximilian Fleischmann, (unknown), Louis Fries, (unknown), Ingeborg Tinhofer, Daniel Zips, Cihan Gani, Claus Rödel, Emmanouil Fokas	4
3	Irradiation alters extracellular vesicle microRNA load in the serum of patients with leukaemia 2024 ·Strahlentherapie und Onkologie ·Stephanie Hehlgans, (unknown), (unknown), Katalin Lumniczky, Gesine Bug, Claus Rödel, Franz Rödel	1
4	944TiP Randomized phase II study of immune stimulation with pembrolizumab and radiotherapy of recurrent and/or metastatic head and neck squamous cell carcinoma : The IMPORTANCE trial 2023 ·Annals of Oncology ·Bálint Tamaskovics, Markus Hecht, Philipp Schubert, Axel Kallies, Thomas Illmer, J. Radke, Oliver Koelbl, Felix Steger, Thomas Brunner, Claus Rödel, Maximilian Fleischmann, Anke Reinacher‐Schick, (unknown), Patrick Melchior, Günther Klautke, (unknown), Udo S. Gaipl, Jan Haussmann, Wilfried Budach, Rainer Fietkau	1
5	pCR and 2-Year Disease-Free Survival: A Combination of the Two Endpoints as a New Classification for Locally Advanced Rectal Cancer Patients—An Updated Pooled Analysis of Eleven International Randomized Trials 2023 ·Cancers ·Maria Antonietta Gambacorta, Giuditta Chiloiro, Carlotta Masciocchi, (unknown), Ângela Romano, Alessandra Gonnelli, Jean‐Pierre Gérard, Samuel Y. Ngan, Claus Rödel, Krzysztof Bujko, Rob Glynne‐Jones, Johan van Soest, André Dekker, Andrea Damiani, Vincenzo Valentini	7
6	Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies 2022 ·Cancers ·(unknown), Robert Wolff, Hanns Ackermann, Markus Meißner, Claus Rödel, (unknown), Georgios Chatzikonstantinou	10
7	Are We There Yet? The Value of Deep Learning in a Multicenter Setting for Response Prediction of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy 2022 ·Diagnostics ·(unknown), (unknown), (unknown), (unknown), Claus Rödel, Ralf‐Dieter Hofheinz, Jürgen Hesser, Frank G. Zöllner, Ulrike Attenberger	10
8	Advances in nanotechnology-based platforms for survivin-targeted drug discovery 2022 ·Expert Opinion on Drug Discovery ·(unknown), Stephanie Hehlgans, (unknown), Claus Rödel, Emmanouil Fokas, Franz Rödel	18
9	A Spatial and Functional Interaction of a Heterotetramer Survivin–DNA-PKcs Complex in DNA Damage Response 2021 ·Cancer Research ·(unknown), Stephanie Hehlgans, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kay Hamacher, Klaus Strebhardt, Emmanouil Fokas, Claus Rödel, Christian Münch, Franz Rödel	9
10	Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study 2021 ·Clinical and Translational Radiation Oncology ·(unknown), Panagiotis Balermpas, Christian Brandts, (unknown), Shahram Ghanaati, Ria Winkelmann, Iris Burck, Franz Rödel, Daniel Martin, Claus Rödel, Jens von der Grün	5
11	Maintenance of Energy Homeostasis during Calorically Restricted Ketogenic Diet and Fasting-MR-Spectroscopic Insights from the ERGO2 Trial 2020 ·Cancers ·Katharina J. Wenger, Marlies Wagner, Patrick N. Harter, Kea Franz, Jörg Bojunga, Emmanouil Fokas, Detlef Imhoff, Claus Rödel, Johannes Rieger, Elke Hattingen, Joachim P. Steinbach, Ulrich Pilatus, Martin Voß	16
12	Prognostic impact of CD8-positive tumour-infiltrating lymphocytes and PD-L1 expression in salivary gland cancer 2020 ·Oral Oncology ·(unknown), Ria Winkelmann, (unknown), Shahram Ghanaati, Daniel Martin, Thomas Neumayer, (unknown), Claus Rödel, Franz Rödel, Jens von der Grün, Panagiotis Balermpas	17
13	The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper 2019 ·Radiotherapy and Oncology ·Vincenzo Valentini, Corrie A.M. Marijnen, Geerard L. Beets, Krzysztof Bujko, Berardino De Bari, Andrés Cervantes, Giuditta Chiloiro, Claudio Coco, Maria Antonietta Gambacorta, Rob Glynne‐Jones, Karin Haustermans, Elisa Meldolesi, Femke P. Peters, Claus Rödel, H.J.T. Rutten, Cornelis J.�H. van de Velde, Cynthia Aristei	8
14	Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with Bevacizumab 2019 ·Journal of Clinical Medicine ·Martin Voß, (unknown), Eike Steidl, Marlies Wagner, Marie-Thérèse Forster, Joachim P. Steinbach, Claus Rödel, Jörg Bojunga, Michael Ronellenfitsch	2
15	Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go? 2019 ·Cancers ·Jens von der Grün, Franz Rödel, Christian Brandts, Emmanouil Fokas, Matthias Gückenberger, Claus Rödel, Panagiotis Balermpas	23
16	Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial 2017 ·Radiation Oncology ·Ping Jiang, (unknown), Reinhard Vonthein, (unknown), (unknown), (unknown), Stefan Huttenlocher, Detlef Imhoff, Panagiotis Balermpas, C. Keller, Kathrin Dellas, René Baumann, Claus Rödel, Guido Hildebrandt, Klaus‐Peter Jünemann, (unknown), Alan J. Katz, Andreas Ziegler, Oliver Blanck, Jürgen Dunst	9
17	Perioperative Therapie des Rektumkarzinoms: Was ist Standard? Wird sich der Standard ändern? 2011 ·Ralf‐Dieter Hofheinz, Claus Rödel	1
18	Failure of Downregulation of Survivin Following Neoadjuvant Radiochemotherapy in Rectal Cancer Is Associated with Distant Metastases and Shortened Survival 2010 ·Clinical Cancer Research ·Thilo Sprenger, Franz Rödel, Tim Beißbarth, Lenard Conradi, (unknown), Kia Homayounfar, Hendrik A. Wolff, Β. Michael Ghadimi, (unknown), Heinz Becker, Claus Rödel, Torsten Liersch	34
19	Radiation-Induced Survivin Nuclear Accumulation is Linked to DNA Damage Repair 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Gianni Capalbo, Klaus Dittmann, Christian Weiß, Sebastian Reichert, (unknown), Claus Rödel, Franz Rödel	54
20	Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer breakdown → 2004 ·New England Journal of Medicine ·Rolf Sauer, Heinz Becker, Werner Hohenberger, Claus Rödel, Christian Wittekind, Rainer Fietkau, Peter Martus, Jörg Tschmelitsch, E. Hager, Clemens F. Hess, (unknown), Torsten Liersch, Heinz Schmidberger, R. Raab	4391

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact